Message

TopSustainabilityMessage

JCR aims to achieve sustainability from an environmental, social and governance (ESG) perspective, with rare diseases, environment, society, and corporate governance as its priority areas.

Since its inception, JCR has developed unique strengths and achieved sustained growth as a company which takes “one step ahead” of competitors at all times. We believe that our core mission is to focus in rare and intractable diseases and develop and create the world’s first innovative biopharmaceuticals originating from Japan.
JCR has defined rare diseases, environment, society, and corporate governance as its priority areas, and is determined to solve issues in each through its business activities. The benefits derived from these activities will be returned to and shared with a broad range of stakeholders within and outside the company. In the process, we aim to achieve sustainability from an ESG perspective.
JCR seeks to be a “Research oriented specialty pharma with global exposure.” Concurrently, we will make a concerted effort to engage in sustainability and steadily realize our corporate philosophy of “Contributing towards people’s healthcare through pharmaceutical products.” We look forward to your continued understanding and support as we endeavor to reach our goals.

Toru Ashida
Senior Executive Director, In charge of Corporate Strategy